Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

Mechanisms shaping the mutational landscape of the FRA3B/FHIT-deficient cancer genome.

Saldivar JC, Park D.

Genes Chromosomes Cancer. 2019 May;58(5):317-323. doi: 10.1002/gcc.22684. Epub 2018 Nov 18. Review.

PMID:
30242938
2.

An intrinsic S/G2 checkpoint enforced by ATR.

Saldivar JC, Hamperl S, Bocek MJ, Chung M, Bass TE, Cisneros-Soberanis F, Samejima K, Xie L, Paulson JR, Earnshaw WC, Cortez D, Meyer T, Cimprich KA.

Science. 2018 Aug 24;361(6404):806-810. doi: 10.1126/science.aap9346.

3.

FHIT, a Novel Modifier Gene in Pulmonary Arterial Hypertension.

Dannewitz Prosseda S, Tian X, Kuramoto K, Boehm M, Sudheendra D, Miyagawa K, Zhang F, Solow-Cordero D, Saldivar JC, Austin ED, Loyd JE, Wheeler L, Andruska A, Donato M, Wang L, Huebner K, Metzger RJ, Khatri P, Spiekerkoetter E.

Am J Respir Crit Care Med. 2019 Jan 1;199(1):83-98. doi: 10.1164/rccm.201712-2553OC.

PMID:
30107138
4.

A new mitotic activity comes into focus.

Saldivar JC, Cimprich KA.

Science. 2018 Jan 5;359(6371):30-31. doi: 10.1126/science.aar4799. No abstract available.

PMID:
29302000
5.

Primary care variability in patients at higher risk for colorectal cancer: evaluation of screening and preventive care practices.

Peabody J, Saldivar JS, Swagel E, Fugaro S, Paculdo D, Tran M.

Curr Med Res Opin. 2018 May;34(5):851-856. doi: 10.1080/03007995.2017.1417244. Epub 2018 Jan 21.

PMID:
29239679
6.

Publisher correction: The essential kinase ATR: ensuring faithful duplication of a challenging genome.

Saldivar JC, Cortez D, Cimprich KA.

Nat Rev Mol Cell Biol. 2017 Dec;18(12):783. doi: 10.1038/nrm.2017.116. Epub 2017 Nov 8. No abstract available.

PMID:
29115300
7.

Incidental Detection of Maternal Neoplasia in Noninvasive Prenatal Testing.

Dharajiya NG, Grosu DS, Farkas DH, McCullough RM, Almasri E, Sun Y, Kim SK, Jensen TJ, Saldivar JS, Topol EJ, van den Boom D, Ehrich M.

Clin Chem. 2018 Feb;64(2):329-335. doi: 10.1373/clinchem.2017.277517. Epub 2017 Oct 5.

8.

The essential kinase ATR: ensuring faithful duplication of a challenging genome.

Saldivar JC, Cortez D, Cimprich KA.

Nat Rev Mol Cell Biol. 2017 Oct;18(10):622-636. doi: 10.1038/nrm.2017.67. Epub 2017 Aug 16. Review. Erratum in: Nat Rev Mol Cell Biol. 2017 Dec;18(12 ):783.

9.

Transcription-Replication Conflict Orientation Modulates R-Loop Levels and Activates Distinct DNA Damage Responses.

Hamperl S, Bocek MJ, Saldivar JC, Swigut T, Cimprich KA.

Cell. 2017 Aug 10;170(4):774-786.e19. doi: 10.1016/j.cell.2017.07.043.

10.

Clinical Impact of Pharmacogenetic-Guided Treatment for Patients Exhibiting Neuropsychiatric Disorders: A Randomized Controlled Trial.

Olson MC, Maciel A, Gariepy JF, Cullors A, Saldivar JS, Taylor D, Centeno J, Garces JA, Vaishnavi S.

Prim Care Companion CNS Disord. 2017 Mar 16;19(2). doi: 10.4088/PCC.16m02036.

11.

Identification of Fhit as a post-transcriptional effector of Thymidine Kinase 1 expression.

Kiss DL, Waters CE, Ouda IM, Saldivar JC, Karras JR, Amin ZA, Mahrous S, Druck T, Bundschuh RA, Schoenberg DR, Huebner K.

Biochim Biophys Acta Gene Regul Mech. 2017 Mar;1860(3):374-382. doi: 10.1016/j.bbagrm.2017.01.005. Epub 2017 Jan 14.

12.

Hospital Outcomes of Robotic Versus Laparoscopic Hysterectomy: A Texas Statewide Analysis.

Lopez S, Saldivar JS, Hernandez LL, Mulla ZD.

J Minim Invasive Gynecol. 2015 Nov-Dec;22(6S):S71-S72. doi: 10.1016/j.jmig.2015.08.191. Epub 2015 Oct 15. No abstract available.

PMID:
27679322
13.

Use of Laparoscopy in Unexplained Infertility in Historically Underserved Area.

Park H, Ramirez D, Noble L, Saldivar JS, Mulla Z.

J Minim Invasive Gynecol. 2015 Nov-Dec;22(6S):S233-S234. doi: 10.1016/j.jmig.2015.08.822. Epub 2015 Oct 15. No abstract available.

PMID:
27679133
14.

Fetal cell-free DNA fraction in maternal plasma is affected by fetal trisomy.

Suzumori N, Ebara T, Yamada T, Samura O, Yotsumoto J, Nishiyama M, Miura K, Sawai H, Murotsuki J, Kitagawa M, Kamei Y, Masuzaki H, Hirahara F, Saldivar JS, Dharajiya N, Sago H, Sekizawa A; Japan NIPT Consortium.

J Hum Genet. 2016 Jul;61(7):647-52. doi: 10.1038/jhg.2016.25. Epub 2016 Mar 17.

PMID:
26984559
15.

Initial assessment of the benefits of implementing pharmacogenetics into the medical management of patients in a long-term care facility.

Saldivar JS, Taylor D, Sugarman EA, Cullors A, Garces JA, Oades K, Centeno J.

Pharmgenomics Pers Med. 2016 Jan 19;9:1-6. doi: 10.2147/PGPM.S93480. eCollection 2016.

16.

Exome-wide single-base substitutions in tissues and derived cell lines of the constitutive Fhit knockout mouse.

Paisie CA, Schrock MS, Karras JR, Zhang J, Miuma S, Ouda IM, Waters CE, Saldivar JC, Druck T, Huebner K.

Cancer Sci. 2016 Apr;107(4):528-35. doi: 10.1111/cas.12887. Epub 2016 Feb 23.

17.

DNA replication stress underlies renal phenotypes in CEP290-associated Joubert syndrome.

Slaats GG, Saldivar JC, Bacal J, Zeman MK, Kile AC, Hynes AM, Srivastava S, Nazmutdinova J, den Ouden K, Zagers MS, Foletto V, Verhaar MC, Miles C, Sayer JA, Cimprich KA, Giles RH.

J Clin Invest. 2015 Sep;125(9):3657-66. doi: 10.1172/JCI80657. Epub 2015 Aug 24.

18.

Clinical outcome of subchromosomal events detected by whole-genome noninvasive prenatal testing.

Helgeson J, Wardrop J, Boomer T, Almasri E, Paxton WB, Saldivar JS, Dharajiya N, Monroe TJ, Farkas DH, Grosu DS, McCullough RM.

Prenat Diagn. 2015 Oct;35(10):999-1004. doi: 10.1002/pd.4640. Epub 2015 Jul 27.

19.

Uterine leiomyoma confounding a noninvasive prenatal test result.

Dharajiya NG, Namba A, Horiuchi I, Miyai S, Farkas DH, Almasri E, Saldivar JS, Takagi K, Kamei Y.

Prenat Diagn. 2015 Oct;35(10):990-3. doi: 10.1002/pd.4629. Epub 2015 Jul 6. No abstract available.

PMID:
26058600
20.

Factors affecting levels of circulating cell-free fetal DNA in maternal plasma and their implications for noninvasive prenatal testing.

Kinnings SL, Geis JA, Almasri E, Wang H, Guan X, McCullough RM, Bombard AT, Saldivar JS, Oeth P, Deciu C.

Prenat Diagn. 2015 Aug;35(8):816-22. doi: 10.1002/pd.4625. Epub 2015 Jul 14.

PMID:
26013964
21.

Detection of fetal subchromosomal abnormalities by sequencing circulating cell-free DNA from maternal plasma.

Zhao C, Tynan J, Ehrich M, Hannum G, McCullough R, Saldivar JS, Oeth P, van den Boom D, Deciu C.

Clin Chem. 2015 Apr;61(4):608-16. doi: 10.1373/clinchem.2014.233312. Epub 2015 Feb 20.

22.

Clinical and pathological characteristics of Hispanic BRCA-associated breast cancers in the American-Mexican border city of El Paso, TX.

Nahleh Z, Otoukesh S, Dwivedi AK, Mallawaarachchi I, Sanchez L, Saldivar JS, Cataneda K, Heydarian R.

Am J Cancer Res. 2014 Dec 15;5(1):466-71. eCollection 2015.

23.

Noninvasive prenatal testing using cell-free fetal DNA in maternal plasma.

Dharajiya N, Zwiefelhofer T, Guan X, Angkachatchai V, Saldivar JS.

Curr Protoc Hum Genet. 2015 Jan 20;84:8.15.1-20. doi: 10.1002/0471142905.hg0815s84. Review.

PMID:
25599670
24.

FHIT loss-induced DNA damage creates optimal APOBEC substrates: Insights into APOBEC-mediated mutagenesis.

Waters CE, Saldivar JC, Amin ZA, Schrock MS, Huebner K.

Oncotarget. 2015 Feb 20;6(5):3409-19.

25.

Non-invasive prenatal chromosomal aneuploidy testing--clinical experience: 100,000 clinical samples.

McCullough RM, Almasri EA, Guan X, Geis JA, Hicks SC, Mazloom AR, Deciu C, Oeth P, Bombard AT, Paxton B, Dharajiya N, Saldivar JS.

PLoS One. 2014 Oct 7;9(10):e109173. doi: 10.1371/journal.pone.0109173. eCollection 2014.

26.

The FHIT gene product: tumor suppressor and genome "caretaker".

Waters CE, Saldivar JC, Hosseini SA, Huebner K.

Cell Mol Life Sci. 2014 Dec;71(23):4577-87. doi: 10.1007/s00018-014-1722-0. Epub 2014 Oct 5. Review.

27.

Noninvasive prenatal testing for microdeletion syndromes and expanded trisomies: proceed with caution.

Bombard AT, Farkas DH, Monroe TJ, Saldivar JS.

Obstet Gynecol. 2014 Aug;124(2 Pt 1):379. doi: 10.1097/AOG.0000000000000400. No abstract available.

PMID:
25050762
28.

Fhit deficiency-induced global genome instability promotes mutation and clonal expansion.

Miuma S, Saldivar JC, Karras JR, Waters CE, Paisie CA, Wang Y, Jin V, Sun J, Druck T, Zhang J, Huebner K.

PLoS One. 2013 Nov 14;8(11):e80730. doi: 10.1371/journal.pone.0080730. eCollection 2013.

29.

EGFR-mutated lung cancer with T790M-acquired resistance in the brain and histologic transformation in the lung.

Scher KS, Saldivar JS, Fishbein M, Marchevsky A, Reckamp KL.

J Natl Compr Canc Netw. 2013 Sep 1;11(9):1040-4.

PMID:
24029120
30.

Common chromosome fragile sites in human and murine epithelial cells and FHIT/FRA3B loss-induced global genome instability.

Hosseini SA, Horton S, Saldivar JC, Miuma S, Stampfer MR, Heerema NA, Huebner K.

Genes Chromosomes Cancer. 2013 Nov;52(11):1017-29. doi: 10.1002/gcc.22097. Epub 2013 Aug 9.

31.

Noninvasive prenatal detection of sex chromosomal aneuploidies by sequencing circulating cell-free DNA from maternal plasma.

Mazloom AR, Džakula Ž, Oeth P, Wang H, Jensen T, Tynan J, McCullough R, Saldivar JS, Ehrich M, van den Boom D, Bombard AT, Maeder M, McLennan G, Meschino W, Palomaki GE, Canick JA, Deciu C.

Prenat Diagn. 2013 Jun;33(6):591-7. doi: 10.1002/pd.4127.

PMID:
23592550
32.

Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology.

Lindeman NI, Cagle PT, Beasley MB, Chitale DA, Dacic S, Giaccone G, Jenkins RB, Kwiatkowski DJ, Saldivar JS, Squire J, Thunnissen E, Ladanyi M, College of American Pathologists International Association for the Study of Lung Cancer and Association for Molecular Pathology.

J Mol Diagn. 2013 Jul;15(4):415-53. doi: 10.1016/j.jmoldx.2013.03.001. Epub 2013 Apr 4. Erratum in: J Mol Diagn. 2013 Sep;15(5):730.

33.

Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology.

Lindeman NI, Cagle PT, Beasley MB, Chitale DA, Dacic S, Giaccone G, Jenkins RB, Kwiatkowski DJ, Saldivar JS, Squire J, Thunnissen E, Ladanyi M.

J Thorac Oncol. 2013 Jul;8(7):823-59. doi: 10.1097/JTO.0b013e318290868f. Erratum in: J Thorac Oncol. 2013 Oct;8(10):1343.

34.

Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology.

Lindeman NI, Cagle PT, Beasley MB, Chitale DA, Dacic S, Giaccone G, Jenkins RB, Kwiatkowski DJ, Saldivar JS, Squire J, Thunnissen E, Ladanyi M.

Arch Pathol Lab Med. 2013 Jun;137(6):828-60. doi: 10.5858/arpa.2012-0720-OA. Epub 2013 Apr 3. Erratum in: Arch Pathol Lab Med. 2013 Sep;137(9):1174.

35.

Prevalence and type of BRCA mutations in Hispanics undergoing genetic cancer risk assessment in the southwestern United States: a report from the Clinical Cancer Genetics Community Research Network.

Weitzel JN, Clague J, Martir-Negron A, Ogaz R, Herzog J, Ricker C, Jungbluth C, Cina C, Duncan P, Unzeitig G, Saldivar JS, Beattie M, Feldman N, Sand S, Port D, Barragan DI, John EM, Neuhausen SL, Larson GP.

J Clin Oncol. 2013 Jan 10;31(2):210-6. doi: 10.1200/JCO.2011.41.0027. Epub 2012 Dec 10. Erratum in: J Clin Oncol. 2013 May 1;31(13):1702.

36.

Initiation of genome instability and preneoplastic processes through loss of Fhit expression.

Saldivar JC, Miuma S, Bene J, Hosseini SA, Shibata H, Sun J, Wheeler LJ, Mathews CK, Huebner K.

PLoS Genet. 2012;8(11):e1003077. doi: 10.1371/journal.pgen.1003077. Epub 2012 Nov 29.

37.

Characterization of the role of Fhit in suppression of DNA damage.

Saldivar JC, Bene J, Hosseini SA, Miuma S, Horton S, Heerema NA, Huebner K.

Adv Biol Regul. 2013 Jan;53(1):77-85. doi: 10.1016/j.jbior.2012.10.003. Epub 2012 Oct 11.

38.

Novel mutation in ARX associated with early hand preference and a mild phenotype.

Kuwaik GA, Saldivar JS, Yoon G.

J Dev Behav Pediatr. 2012 Sep;33(7):586-8. doi: 10.1097/DBP.0b013e31825e2310.

PMID:
22922607
39.

Community-based rapid oral human immunodeficiency virus testing for tuberculosis patients in Lima, Peru.

Nelson AK, Caldas A, Sebastian JL, Muñoz M, Bonilla C, Yamanija J, Jave O, Magan C, Saldivar J, Espiritu B, Rosell G, Bayona J, Shin S.

Am J Trop Med Hyg. 2012 Sep;87(3):399-406. doi: 10.4269/ajtmh.2012.12-0036. Epub 2012 Jul 23.

40.

Fibulin-3 promotes glioma growth and resistance through a novel paracrine regulation of Notch signaling.

Hu B, Nandhu MS, Sim H, Agudelo-Garcia PA, Saldivar JC, Dolan CE, Mora ME, Nuovo GJ, Cole SE, Viapiano MS.

Cancer Res. 2012 Aug 1;72(15):3873-85. doi: 10.1158/0008-5472.CAN-12-1060. Epub 2012 Jun 4.

41.

A review of the ecology, genomics, and stress response of Listeria innocua and Listeria monocytogenes.

Milillo SR, Friedly EC, Saldivar JC, Muthaiyan A, O'Bryan C, Crandall PG, Johnson MG, Ricke SC.

Crit Rev Food Sci Nutr. 2012;52(8):712-25. doi: 10.1080/10408398.2010.507909. Review.

PMID:
22591342
42.

Response of subtype-specific human breast cancer-derived cells to poly(ADP-ribose) polymerase and checkpoint kinase 1 inhibition.

Shibata H, Miuma S, Saldivar JC, Huebner K.

Cancer Sci. 2011 Oct;102(10):1882-8. doi: 10.1111/j.1349-7006.2011.02016.x. Epub 2011 Jul 21.

43.

Hits, Fhits and Nits: beyond enzymatic function.

Huebner K, Saldivar JC, Sun J, Shibata H, Druck T.

Adv Enzyme Regul. 2011;51(1):208-17. doi: 10.1016/j.advenzreg.2010.09.003. Epub 2010 Oct 28. Review.

44.

p16INK4a expression in basal-like breast carcinoma.

Bohn OL, Fuertes-Camilo M, Navarro L, Saldivar J, Sanchez-Sosa S.

Int J Clin Exp Pathol. 2010 Jun 30;3(6):600-7.

45.

Pathology and biology associated with the fragile FHIT gene and gene product.

Saldivar JC, Shibata H, Huebner K.

J Cell Biochem. 2010 Apr 1;109(5):858-65. doi: 10.1002/jcb.22481. Review.

PMID:
20082323
46.
47.

Identification of human papillomavirus in esophageal squamous papillomas.

Bohn OL, Navarro L, Saldivar J, Sanchez-Sosa S.

World J Gastroenterol. 2008 Dec 14;14(46):7107-11.

48.

The updated concept of genome and its implications in biotechnological research and molecular diagnostics.

Xiao L, Saldivar JS, Zhou C, Chen C, Zhang J, Sirois P, Li K.

Mol Biotechnol. 2009 Feb;41(2):152-6. doi: 10.1007/s12033-008-9105-0. Epub 2008 Sep 20.

PMID:
18802794
49.

p53 Testing for Li-Fraumeni and Li-Fraumeni-like syndromes.

Gonzalez K, Fong C, Buzin C, Sommer SS, Saldivar JS.

Curr Protoc Hum Genet. 2008 Apr;Chapter 10:Unit 10.10. doi: 10.1002/0471142905.hg1010s57.

PMID:
18428420
50.

EGF receptor testing for non-small cell lung carcinomas.

Saldivar JS, Chen Z, Sommer S.

Curr Protoc Hum Genet. 2006 Aug;Chapter 10:Unit 10.9. doi: 10.1002/0471142905.hg1009s50. Review.

PMID:
18428387

Supplemental Content

Loading ...
Support Center